| Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
|---|
₹ 35000
| EX1639 ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL | |||||||
| Specimen: | 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. | ||||||
| Stability: |
|
||||||
| Method: | NGS | ||||||
| Comment: | Samples received on holidays will be reported in the next schedule/next working day. | ||||||
| Report: | Contact us to know the TAT. | ||||||
| Usage: | Acute myeloid leukemia (AML) is a neoplastic disease of the hematopoietic stem cell defined by impaired differentiation capacity, clonal expansion, and accumulation of immature cells with suppression of polyclonal residual hematopoiesis. The resulting peripheral cytopenias account for the most frequent clinical symptoms at diagnosis (fatigue, dyspnea, fever and infections, hemorrhage). The sequencing of genes related to the pathophysiology of AML helps in making diagnoses, and also for prognostication and therapeutic decision making. | ||||||
| Doctor Specialty: | Hematologist, Oncologist | ||||||
| Disease: | Leukemia | ||||||
| Components: | ABL1, ASXL1, BCOR, BAALC, CBL, CEBPA, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS, MYD88, MYC, MECOM, NRAS, NPM1, NF1, PHF6, PPRF8, PTPN11, RUNX1, SF3B1, SRSF2, SMC1A, SH2B3, STAG2, TET2, TP53, U2AF1, WT1, ZRSR2 FUSION GENES – ABL1, BCL2, CCND1, CREBBP, ETV6, FGFR1, FGRF2, FUS, HMGA2, JAK2, KMT2A, MECOM, MLL, MYH11, MMLT3, MLLT10, NTRK3, NUP214, PDGFRA, PDGFRB, RARA, RBM15, RUNX1, TCF3 | ||||||
| Courier Charges: | |||||||
| Home Collection: | Available (*T&C Apply) | ||||||
| Department: | MOLECULAR DIAGNOSTICS | ||||||
| Pre Test Information: | A duly filled NGS Test Requisition Form is mandatory. | ||||||
Reviews
There are no reviews yet.